APP and Alzheimer disease: Presenilin 1 and presenilin 2 (PS1 and PS2) enhance the processing of transmembrane APP cleaved by alpha and beta proteases and gamma-secretases to form beta-amyloid 42 [8], which subsequently results in the development of AD.